These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39316288)

  • 1. The Correlation Between Body Mass Index and Health-Related Quality of Life: Data from Two Weight Loss Intervention Studies.
    Kral P; Holst-Hansen T; Olivieri AV; Ivanescu C; Lamotte M; Larsen S
    Adv Ther; 2024 Nov; 41(11):4228-4247. PubMed ID: 39316288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
    Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ
    Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis.
    Mukuria C; Rowen D; Acaster S; McGarry LJ; Lou Y; Sosnay PR; Quittner AL
    J Patient Rep Outcomes; 2024 Feb; 8(1):24. PubMed ID: 38416239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
    Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.
    Harvie HS; Honeycutt AA; Neuwahl SJ; Barber MD; Richter HE; Visco AG; Sung VW; Shepherd JP; Rogers RG; Jakus-Waldman S; Mazloomdoost D;
    Am J Obstet Gynecol; 2019 Mar; 220(3):265.e1-265.e11. PubMed ID: 30471259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey.
    Kularatna S; Senanayake S; Gunawardena N; Graves N
    BMJ Open; 2019 Feb; 9(2):e024854. PubMed ID: 30772857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
    J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
    Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M
    Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?
    Torrance N; Lawson KD; Afolabi E; Bennett MI; Serpell MG; Dunn KM; Smith BH
    Pain; 2014 Oct; 155(10):1996-2004. PubMed ID: 25020004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalog of EQ-5D-3L Health-Related Quality-of-Life Scores for 199 Chronic Conditions and Health Risks in Denmark.
    Hvidberg MF; Petersen KD; Davidsen M; Witt Udsen F; Frølich A; Ehlers L; Alava MH
    MDM Policy Pract; 2023; 8(1):23814683231159023. PubMed ID: 37056295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
    Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP
    Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of EuroQol-5D-3L and Short Form-6D Utility Scores in Family Caregivers of Colorectal Cancer Patients: A Cross-Sectional Survey in China.
    Sun CY; Liu Y; Zhou LR; Wang MS; Zhao XM; Huang WD; Liu GX; Zhang X
    Front Public Health; 2021; 9():742332. PubMed ID: 34660519
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment effect of semaglutide 2.4 mg on health-related quality of life from STEP 1 SF-6D derived from SF-36 with Australian weights.
    Kral P; Allen FL; Larsen S; Holst-Hansen T; Olivieri AV; Manton A
    Diabetes Obes Metab; 2024 Apr; 26(4):1171-1179. PubMed ID: 38195847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring Health Spillover Effects in Caregivers of Children with Autism Spectrum Disorder: A Comparison of the EQ-5D-3L and SF-6D.
    Brown CC; Tilford JM; Payakachat N; Williams DK; Kuhlthau KA; Pyne JM; Hoefman RJ; Brouwer WBF
    Pharmacoeconomics; 2019 Apr; 37(4):609-620. PubMed ID: 30864066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
    Tramontano AC; Schrag DL; Malin JK; Miller MC; Weeks JC; Swan JS; McMahon PM
    Med Decis Making; 2015 Apr; 35(3):371-87. PubMed ID: 25670839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between health-related quality of life and body mass after adjustable gastric banding: a nonlinear approach.
    Lin VW; Wong ES; Wright A; Flum DR; Garrison LP; Alfonso-Cristancho R; Sullivan SD
    Value Health; 2013; 16(5):823-9. PubMed ID: 23947976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.